Global Immunology Market to 2022 - Large pipeline and competitive market to drive long-term market growth

1. Global Immunology Market to 2022 - Large pipeline and competitive market to drive long-term market growth Publisher : GBI Research Publication Date: Dec2015 Number of Pages: 133 Single User license: USD 4995 Site User license: USD 9990 Enterprisewide User license: USD 14985 Contact us : info@marketreportscenter.com call: 1-646-883-3044

2. Scope: Although the patents for many of these mAbs either have already expired or are due to expire during the forecast period, the market is expected to experience continued growth, from $61.5 billion in 2015 to $74.2 billion in 2022, at a compound annual growth rate of 2.71%. - What factors are driving the market growth?- How can the factors limiting growth be overcome?There is a very large pharmaceutical pipeline for immunology, consisting of 1,838 products in active development. However, the commercial performance of the products in the late-stage pipeline is expected to be moderate.- What gaps in the market are being addressed by the most promising of these late-stage pipeline products?- How does the composition of the pipeline compare with that of the existing market?Several key commercially successful products, including Humira (adalimumab) and Remicade, are due to lose patent protection in the forecast period.- How will this affect their revenues in this period?- How are their manufacturers, AbbVie and Johnson & Johnson, responding to this?The key players in the market, all of which are among the top 20 pharmaceutical companies, are expected to maintain their market lead throughout the forecast period.- What is driving this continued market dominance?- Who will the new market players be? Contact us : info@marketreportscenter.com call: 1-646-883-3044

3. According to a recent study, the infections caused by rotavirus every year across the world is around 111 million; with approximately 2 million hospitalizations and 400,000 deaths of children under 5 years old alone. The under developed and developing countries such as Asia, Africa and some more are the biggest target regions for the earlier mentioned statistics. Around 82% of the total cases are registered from the children in Asia and Africa. • Also, the dangerous HBV affected almost 1.4 million of the US population in 2011 and has been acting as major public health challenge ever since. The swine flu virus, zika virus, in the latest records plus additional infections has deteriorated the situation in the past few years (with zika spreading currently). All these outbursts will lead to the growth and strengthening of the Immunology Market during the coming few years. • The complexity of the immune system has led to some intrinsic obstacles with clinical research, particularly in relation to targeting the right genes, identifying the appropriate patient population and accessing internal tissues for testing. Market access presents a significant hurdle for immunotherapeutic procedures, as many are high cost and do not deliver the measurements required for traditional cost-effectiveness assessments. Despite these restraining factors, The Global Immunology Market is expected to experience continued growth, from $61.5 Billion in 2015 to $74.2 Billion in 2022, at 2.71% CAGR. Contact us : info@marketreportscenter.com call: 1-646-883-3044

4. Reasons to buy : • This report will allow you to -  - Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis and the treatment options available at each stage of diagnosis - Visualize the composition of the immunology market across each indication, in terms of dominant molecule types and targets, highlighting the key commercial assets and players - Analyze the immunology pipeline and stratify by stage of development, molecule type and molecular target, with a granular breakdown across key indications - Understand the growth in patient epidemiology and market revenues for the immunology market globally and across the key players and product types - Stratify the market in terms of the split between generic and premium products and assess the role of these product types in the treatment of the various immunological disorders - Identify commercial opportunities in the immunology deals landscape by analyzing trends in licensing and co-development deals Contact us : info@marketreportscenter.com call: 1-646-883-3044

5. Companies Profiled • Apart from the market segmentation, Key Market Insights on the Past, Future & Present of the Immunology Market, this report includes an in-depth analysis and study on the Key Players at a Global Scale. • AbbVie , Johnson & Johnson , Amgen , Genentech / Roche , Astellas , UCB , Eli Lilly , Sanofi , Astra Zeneca , Novartis and many more key players of Immunology Market are mentioned in this report on Immunology Market. The key players in the market, all of which are among the top 20 pharmaceutical companies, are expected to maintain their market lead throughout the forecast period 2015-2022. Contact us : info@marketreportscenter.com call: 1-646-883-3044

6. Full Report at : https://marketreportscenter.com/reports/97188/global-immunology-market-to-2022/ Reach us at: info@marketreportscenter.com sam@marketreportscenter.com Visit us : www.marketreportscenter.com Call us at : 1-646-883-3044 (US) +91- 20-41217796 (IND) Follow us: FacebookTwitterLinkedin